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http://Contents lists available at ScienceDirectEditorialRadiocontrast-induced nephropathy in patients with liver
cirrhosis and chronic kidney diseaseRadiocontrast-induced nephropathy (RCIN) represents one inaccurate, especially in decompensated cirrhotic patients,
of the leading causes of hospital-acquired acute kidney injury
(AKI) worldwide, and due to an increase in the number of
procedures that use contrast agents for various diagnostic and
therapeutic purposes, especially in high-risk patients, the
incidence of RCIN has been reported to be up to 25% in
patients with chronic kidney disease (CKD) [1,2]. Although
the typical clinical course of CIN is known to be characterized
by an early peak of serum creatinine concentration in 3–5
days, returning to baseline within 7 days, it can also be
associated with a more severe and prolonged course of AKI
in patients with CKD, with a possible deleterious impact on
the progression of CKD [3–5].
The pathogenesis of RCIN includes a combination of renal
ischemia, direct and indirect tubule toxicity mediated by
reactive oxygen species, and tubule obstruction. Therefore,
various drugs and clinical conditions that can reduce renal
plasma ﬂow or impair renal autoregulatory function might
serve as risk factors; these may include decreased true or
effective circulating volume, diabetes mellitus, presence of
CKD, shock, or the use of nonsteroidal anti-inﬂammatory
drugs. However, despite a better understanding of the patho-
genesis, there are no speciﬁc treatment strategies, and in
clinical practice hydration with isotonic sodium chloride or
sodium bicarbonate for the purpose of maintaining urine ﬂow
remains a mainstay in prevention.
Cirrhosis of the liver is a condition that is characterized by
the replacement of liver tissue by ﬁbrosis, scar tissue, and
regenerative nodules, which ultimately leads to a loss of liver
function. The presence of acute or chronic renal complications
is common in these patients, and is known to be associated
with poorer outcome. Cirrhotic patients are likely to be prone
to the development of an acute deterioration of kidney
function, due to the presence of a reduced effective circulating
volume, which is often aggravated by the use of diuretics,
large-volume paracentesis, or gastrointestinal bleeding [6].
Furthermore, the presence of hyperaldosteronism, altered
renal hemodynamics, or infection can escalate susceptibility
to the development of AKI. Although the most common form
of renal complications in cirrhotic patients is hemodynami-
cally mediated functional impairment, the concomitant pre-
sence of CKD is also common. However, in diagnosing CKD or
AKI, serum creatinine concentration is known to be more132/$ - see front matter & 2015. The Korean Society of Nephrology. P
nse (http://creativecommons.org/licenses/by-nc-nd/4.0/).
dx.doi.org/10.1016/j.krcp.2012.04.324possibly due to a reduced production of creatinine from
creatine in the liver, and also due to the concurrent presence
of muscle wasting. Therefore, the use of creatinine-based
estimated glomerular ﬁltration rate (eGFR) has more limita-
tions in these patients.
With advances in antiviral and supportive care, the long-
evity of cirrhotic patients has increased, and it is expected
that the use of radiocontrast for computed tomography (CT)
scanning or angiography with the purpose of early recogni-
tion and proper treatment of hepatocellular carcinoma or for
other co-morbid conditions will rise. Additionally, both a
reduced effective circulating volume and altered renal hemo-
dynamics per se in cirrhotic patients are expected to increase
the incidence of RCIN. However, whether liver cirrhosis itself
portends an added risk factor in the development of RCIN, or
whether preventive strategies such as hydration with normal
saline or sodium bicarbonate could be safely carried out in
these patients, has not been thoroughly investigated.
In this issue of Kidney Research and Clinical Practice, Choi
et al evaluated the incidence of RCIN in patients with liver
cirrhosis and CKD (eGFR r60 mL/min/1.73 m2). They also
tested the effect of intravenous albumin for prophylaxis of
RCIN. By retrospectively comparing the incidence of RCIN in
81 patients, deﬁned as Z25% or Z0.5 mg/dl rise in serum
creatinine concentration measured 2–5 days after CT scan-
ning, they ﬁrst demonstrated that the overall incidence of
RCIN in patients with liver cirrhosis and CKD who received
RCIN prophylaxis protocols that included N-acetylcysteine
with sodium bicarbonate or albumin was relatively low
(3.7%). They also showed that there was no difference in the
incidence of RCIN between sodium bicarbonate and albumin
prophylaxis. As the authors quoted, only three studies so far
have examined the incidence of RCIN in patients with liver
cirrhosis, and their results have been controversial [7–9].
Although the exact reasons for the discrepancy in the
results between the studies are not known, this current study
by Choi et al has strengths in that it examined the incidence of
RCIN in patients with combined liver cirrhosis and CKD for
the ﬁrst time. In addition, despite several limitations of this
study, it is noteworthy for its observation that the overall
incidence of RCIN in patients with combined liver cirrhosis
and CKD who underwent prophylactic procedures was low.ublished by Elsevier. This is an open access article under the CC BY-NC-
Editorial / Kidney Res Clin Pract 31 (2012) 85–8686However, due to the absence of a control group who did not
receive prophylaxis, it remains unclear whether this relatively
low incidence of RCIN originated from the prophylaxis.
Additionally, because the incidence of RCIN in patients with
combined liver cirrhosis and CKD was not compared with that
in patients with CKD alone, we cannot tell from this study
whether liver cirrhosis itself might further increase the risk
of RCIN.
In assessing the risk factors for the development of RCIN in
these patients, only the presence of ascites was found to be a
risk factor, but diabetes mellitus and lower eGFR, well-known
traditional risk factors for RCIN, were not associated with the
development of RCIN. Although the presence of ascites in
cirrhotic patients has also been demonstrated to be an
independent risk factor for RCIN in another study by Lohida
et.al, caution should be taken in drawing them same conclu-
sion from this study because, due to a very limited number of
RCIN cases, the number of patients was too small to convin-
cingly deﬁne the risk factors.
The other purpose of this study was to examine the effect
of albumin prophylaxis on the prevention of RCIN. Albumin is
currently used as a volume expander in large-volume para-
centesis or as a bridge therapy to liver transplantation in
hepatorenal syndrome. Albumin infusion, instead of isotonic
sodium chloride or sodium bicarbonate infusion, may have
theoretical advantages in terms of a more effective expansion
of intravascular volume or through its possible antioxidant
effect. Two out of the 38 patients who received albumin
prophylaxis developed RCIN (5.3%), compared with 2.3% (1/43)
in the sodium bicarbonate group, and this difference was not
statistically signiﬁcant. However, as mentioned earlier,
because the number of RCIN cases in both groups was too
small, no meaningful conclusion can be drawn regarding the
effect of albumin prophylaxis. Furthermore, signiﬁcant differ-
ences in the baseline characteristics, such as a more severe
degree of liver dysfunction, which was represented by a
higher Child–Pugh class or a higher prevalence of ascites in
the albumin prophylaxis group, make data interpretation
more complicated. The authors demonstrated that patients
in the albumin prophylaxis group showed a lower degree of
weight gain after a CT scan (0.170.9 vs 0.570.7 kg). How-
ever, we have to consider whether the possible clinical beneﬁt
of lesser weight gain, of about 0.4 kg, in the albumin prophy-
laxis group indeed outweighed the possible negative effects of
albumin infusion—possible viral transmission despite a low
incidence and also higher economic costs.
The concomitant presence of CKD in cirrhotic patients is
increasingly recognized in clinical practice, and episodes of
AKI, including RCIN, in these patients might be associated
with a faster progression of CKD. Although liver cirrhosis itself
is often considered to be a risk factor for RCIN, the incidence,
risk factors, or effects of conventional hydration strategies in
these patients are largely unknown. Recognition of the exact
incidence and risk factors in these particular patient popula-
tions is of great importance in establishing proper preventive
strategies, potentially having a positive impact on patients’
outcome.Recently, a new working party, which consists of members
of the Acute Dialysis Quality Initiative and International
Ascites Club, proposed a newer classiﬁcation system for AKI
in cirrhotic patients [10]. Only an increase in serum creatinine
concentration of 50% from the baseline or 0.3 mg/dl or more
during the 48 hours was chosen, excluding urinary output
criteria owing to a possible lack of reliability of the urine
output in patients with refractory ascites. Based on this newer
classiﬁcation system, large-scale, multicenter, prospective
clinical trials are urgently needed to develop and validate
the risk quantiﬁcation, and also establish preventive strate-
gies for RCIN in patients with liver cirrhosis.Conﬂict of interest
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